Skip to content

FBM

Active
Non-profit association·Overige zakelijke dienstverlening, neg· 1 yrs active
Sint-Michielsstraat 18 ·9000 Gent, Belgium
KBO/BCE: BE 1016.786.167
Watch Print / PDF
Age1 yr
Board22
Staff (FTE)14
Connections74
Real estate1 parcel · 334 m²

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of FBM is < 0.1% (very low). The 2025 annual accounts show equity of €782k and a net result of €-503k. Its solvency ranks better than 51% of 147 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 1 annual account.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
< 0.1% Very low
0%0,5%1,5%4%10%≥25%
Lower-risk legal form −Lower-failure-rate sector −Young company +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Trust signals

2 signals
Young company
Founded in 2024, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No administrative flags

Financials

Turnover€1.35M
EBIT margin-36.8%
Net result€-503k
Working capital€819k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 27-05-2026 with the NBB · fiscal year 2025 · verkort
Sector comparison
Fiscal year 2025 · NACE 82 · compared within the same schema type (abbreviated schema)
Metric This company Sector median Position in the sector
Solvency 40.8% 39.6%
better than 51% of 147 sector peers
Net result €-503k €51k
better than 5% of 146 sector peers
Equity €782k €152k
better than 78% of 147 sector peers
Gross operating margin €1.17M €110k
better than 91% of 144 sector peers
Staff costs €1.56M €234k
higher than 85% of 38 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Fiscal year2025
Revenue€1.35M
EBITDA€-390k
Net profit€-503k
Cash flow€-395k
Staff costs€1.56M
Income taxes€2k
Dividends-
Total assets€1.92M
Equity€782k
Debt€1.13M
of which ≤ 1y€797k
of which > 1y€49k
Working capital€819k
Employees (FTE)14.0
Ratios (computed)
2025
Current ratio2.03
Quick ratio2.03
Working capital ratio42.7%
Solvency40.8%
Debt / equity1.45
Long-term debt ratio0.06
Interest coverage-31.30
Gross margin-85.2%
Net margin-37.2%
ROA-26.2%
ROE-64.3%
EBITDA margin-28.8%
Days sales outstanding101d
Days payable outstanding84d
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€1.92M
Fixed assets 21/28€179k
Formation expenses 20€121k
Intangible fixed assets 21€63k
Tangible fixed assets 22/27€116k
Current assets 29/58€1.62M
Amounts receivable within one year 40/41€468k
Investments 50/53€301k
Cash & bank 54/58€187k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.92M
Equity 10/15€782k
Reserves 13€436k
Accumulated profits (losses) 14€346k
Amounts payable 17/49€1.13M
Amounts payable after one year 17€49k
Amounts payable within one year 42/48€797k
Trade debts payable within one year 44€576k
Income statement
Turnover 70€1.35M
Gross operating margin 9900€1.17M
Operating result 9901€-499k
Financial income 75€10k
Financial charges 65€12k
Result before taxes 9903€-501k
Income taxes 67/77€2k
Net result for the period 9904€-503k
Result to be appropriated 9905€-503k
Ratios computed by Checked.

Health barometer

FY 2025 · computed
38 / 100 Weak
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Directors

Directors & mandates

29 directors
Current directors & mandates
  • Ad Hoc ClinicalLegal entity
    Director· perm. rep.: Nancy Cottigny
    State Gazette act 25124915 (03-10-2025)
    Current
    03-10-2025 → present
  • AllegroLegal entity
    Director· perm. rep.: Lucas Decuypere
    State Gazette act 25124915 (03-10-2025)
    Current
    03-10-2025 → present
  • Benno TherapeuticsLegal entity
    Director· perm. rep.: Erwin Blomsma
    State Gazette act 25124915 (03-10-2025)
    Current
    03-10-2025 → present
  • Flen HealthLegal entity
    Director· perm. rep.: Philippe Sollie
    State Gazette act 25124915 (03-10-2025)
    Current
    03-10-2025 → present
  • GynaiaLegal entity
    Director· perm. rep.: Herman Verrelst
    State Gazette act 25124915 (03-10-2025)
    Current
    03-10-2025 → present
  • Janssen PharmaceuticaLegal entity
    Director· perm. rep.: Tom Aelbrecht
    State Gazette act 25124915 (03-10-2025)
    Current
    24-05-2025 → present
  • Aphea.BioLegal entity
    Director· perm. rep.: Isabel Julia René VERCAUTEREN
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • BIOQUBE VENTURESLegal entity
    Director· perm. rep.: Dirk Maria Jozef REYN
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • GALAPAGOSLegal entity
    Director· perm. rep.: Marieke Francine VERMEERSCH
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • Heran PartnersLegal entity
    Director· perm. rep.: Herman Karel Gabriel VERRELST
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • HippocreatesLegal entity
    Director· perm. rep.: Dirk LOECKX
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • Janssen PharmaceuticaLegal entity
    Director· perm. rep.: Werner Hendrik Adolf VERBIEST
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • Katholieke Universiteit te LeuvenLegal entity
    Director· perm. rep.: Christel Alphonsina Gabriella Godelieve VAN GEET
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
  • Montis BiosciencesLegal entity
    Director· perm. rep.: Gil Hendrik August BEYEN
    State Gazette act 25038689 (24-03-2025)
    Current
    18-02-2025 → present
+ 8 not shown in this overview
Former directors (7)
  • BioQube VenturesLegal entity
    Director· perm. rep.: Dirk Reyn
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • GalapagosLegal entity
    Director· perm. rep.: Marieke Vermeersch
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • Heran PartnersLegal entity
    Director· perm. rep.: Herman Verrelst
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • Montis BiosciencesLegal entity
    Director· perm. rep.: Gil Beyen
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • MoveUpLegal entity
    Director· perm. rep.: Ward Servaes
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • QbD 'GroupLegal entity
    Director· perm. rep.: Bart Van Acker
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
  • VirovetLegal entity
    Director· perm. rep.: Erwin Blomsma
    State Gazette act 25124915 (03-10-2025)
    Former
    - → 03-10-2025
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.

Insolvency mandates

No insolvency mandates (liquidators, administrators) on record for this company.

Legal Structure

NACE primary Overige zakelijke dienstverlening, neg(82990)
Legal form Non-profit association(017)
Incorporation29-11-2024
StatusActive
Postal code9000

Structure & network

Connections & network

74 connected companies
Aphea.Bio, Parent company AAphea.BioBIOQUBE VENTURES, Parent company BVBIOQUBEVENTURESGALAPAGOS, Parent company GGALAPAGOSHeran Partners, Parent company HPHeran PartnersHippocreates, Parent company HHippocreatesJanssen Pharmaceutica, Parent company JPJanssenPharmaceuticaKatholieke Universiteit te Leuven, Parent company KUKatholiekeUniversi…euvenMontis Biosciences, Parent company MBMontisBiosciencesMoveUP, Parent company MMoveUPParticipatiemaatschappij Vlaanderen, Parent company PVParticip…appijVlaanderenQbD Group, Parent company QGQbD GroupStudiecentrum voor Kernenergie - Centre d'Etude de l'Energie Nucléaire, Parent company SVStudiecentrumvoor Ker…éaireSURGI-TEC, Parent company SSURGI-TECUniversitair Ziekenhuis Antwerpen, Parent company UZUniversitairZiekenhu…erpenFBM FBM1016.786.167
Group structure
Group structure
Aphea.Bio
Parent · 1 subsidiary · 1 location
Control→
BIOQUBE VENTURES
Parent · 1 subsidiary · 2 locations
Control→
GALAPAGOS
Parent · 1 subsidiary · 3 locations
Control→
Heran Partners
Parent · 5 subsidiaries · 1 location
Control→
Hippocreates
Parent · 1 subsidiary · 1 location
Control→
Janssen Pharmaceutica
Parent · 2 subsidiaries · 12 locations
Control→
Katholieke Universiteit te Leuven
Parent · 9 subsidiaries · 59 locations
Control→
Montis Biosciences
Parent · 1 subsidiary · 1 location
Control→
MoveUP
Parent · 1 subsidiary · 2 locations
Control→
Participatiemaatschappij Vlaanderen
Parent · 45 subsidiaries · 1 location
Control→
QbD Group
Parent · 1 subsidiary · 1 location
Control→
Control→
SURGI-TEC
Parent · 1 subsidiary · 1 location
Control→
Universitair Ziekenhuis Antwerpen
Parent · 1 subsidiary · 3 locations
Control→
ViroVet
Parent · 1 subsidiary · 1 location
Control→
Control→
Network connections
Aelin Therapeutics
Shared corporate director
→
AMARON
Shared corporate director
→
Ardoyen
Shared corporate director
→
Arts Gebroeders immobilière
Shared corporate director
→
Belgian Offshore Platform
Shared corporate director
→
BELWIND
Shared corporate director
→
BLUE GATE ANTWERP PUBLIC HOLDING
Shared corporate director
→
CITYMESH INTEGRATOR
Shared corporate director
→
Confo Therapeutics
Shared corporate director
→
CONTENTO
Shared corporate director
→
DBFM Scholen van Morgen
Shared corporate director
→
EUROPEAN UNIVERSITY HOSPITAL ALLIANCE
Shared corporate director
→
→
FEops
Shared corporate director
→
GIGARANT
Shared corporate director
→
Groen Licht Vlaanderen
Shared corporate director
→
GS1 Belgium & Luxembourg
Shared corporate director
→
Hexagon Invest
Shared corporate director
→
HEXAGON INVEST II
Shared corporate director
→
HOF van LORREINEN
Shared corporate director
→
Hubspot Belgium
Shared corporate director
→
icometrix
Shared corporate director
→
iFLUX
Shared corporate director
→
ImmuneSpec
Shared corporate director
→
Indigo Diabetes
Shared corporate director
→
Inmanta
Shared corporate director
→
INNOVATION FUND
Shared corporate director
→
InOpSys
Shared corporate director
→
InvestSuite
Shared corporate director
→
Kwaliteitscentrum voor Diagnostiek
Shared corporate director
→
LEUVEN KLIMAATNEUTRAAL 2030
Shared corporate director
→
Leuven MindGate
Shared corporate director
→
LINEAS GROUP
Shared corporate director
→
Magics Technologies
Shared corporate director
→
MyCartis
Shared corporate director
→
→
PANQUIN CONSTRUCT
Shared corporate director
→
PANQUIN LAND
Shared corporate director
→
Plopsa Station Antwerp
Shared corporate director
→
PMV - Standaardleningen
Shared corporate director
→
PROMAN Agilitas
Shared corporate director
→
QustomDot
Shared corporate director
→
REIN4CED
Shared corporate director
→
RENEWABLE ENERGY BASE OSTEND
Shared corporate director
→
ReWind Therapeutics
Shared corporate director
→
RheaVita
Shared corporate director
→
SCHOOL INVEST
Shared corporate director
→
ST Engineering iDirect (Europe) CY
Shared corporate director
→
→
SupplyStack
Shared corporate director
→
THE BELGIAN CHOCOLATE EXPERIENCE
Shared corporate director
→
The Fourth Law
Shared corporate director
→
TRENDMINER
Shared corporate director
→
UgenTec
Shared corporate director
→
Vlaams Energiebedrijf
Shared corporate director
→
WANDELAAR INVEST
Shared corporate director
→
XFA
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.

Locations & real estate

Establishment units

1 location
FBM
Sint-Michielsstraat 18, 9000 GentActiviteiten van bedrijfs- en werkgeversorganisaties
since 20252.370.455.316
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area334 m²
Buildings1
Building footprint334 m²

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44815F1325/00D000
ProtectedMonumentHotel de Nockere: gevels en dakenSource ↗
 Flanders 334 m² 1 · 334 m² -
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

6 acts
All acts · 6 updated 2 months ago
2026
29-05-2026 3 directors appointed Director changes
  • mr. Frederik Van Remoortel, Dagelijks bestuur
  • mr. Ward Overlaet, Dagelijks bestuur
  • mr. Anass Arbage, Dagelijks bestuur
2025
03-10-2025 6 directors appointed, 7 resigning Director changes
  • Lucas Decuypere, Bestuurder
  • Philippe Sollie, Bestuurder
  • Erwin Blomsma, Bestuurder
  • Herman Verrelst, Bestuurder
  • Nancy Cottigny, Bestuurder
  • Tom Aelbrecht, Bestuurder
  • Marieke Vermeersch, Bestuurder
  • Erwin Blomsma, Bestuurder
Summary: v3.2
24-03-2025 16 directors appointed Director changes
  • Gil Hendrik August BEYEN, Bestuurder
  • Isabel Julia René VERCAUTEREN, Bestuurder
  • Erwin BLOMSMA, Bestuurder
  • Marieke Francine VERMEERSCH, Bestuurder
  • Jérôme Laurent Nicole VAN BIERVLIET, Bestuurder
  • Kenneth Maria WILS, Bestuurder
  • Bart Jeanne Freddy VAN ACKER, Bestuurder
  • Dirk Maria Jozef REYN, Bestuurder
Summary: v3.2
24-02-2025 Articles of association amended Statutes amendment
Summary: v3.2
24-02-2025 Change in the board of directors Director changes
Summary: v3.2
2024
10-12-2024 Incorporation of a new VZW Incorporation
Summary: oprichting

Analysis

Snowflake analysis

financial profile on 5 axes
Health38Profitability0Solvency85Growth-Stability67
48 / 100

Mixed profile: strong on solvency, weaker on profitability.

Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.

Health 38
Profitability 0
Solvency 85
Growth -
Stability 67

Ask AI about this company

Checked AI

Soon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.

TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soon

AI due-diligence brief

Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works

Credit advice

verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Same sector, ranked by comparable size

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Overige zakelijke dienstverlening, neg82990Activiteiten van bedrijfs- en werkgeversorganisaties94110Speur- en ontwikkelingswerk op biotechnologisch gebied72101Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg74999Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering94993
Primary activity highlighted.
Names & trade names
Legal nameNL FBM
Registered office
Sint-Michielsstraat 18
9000 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.